Search Results

This week's highlight includes congrats to: David A Cooper, David Minh, et al., for their research on

Kenakin attributes this to limited cooperativity: the allosteric ligand can only shift receptor affinity Mechanistically: The allosteric ligand imposes a finite change in affinity (cooperativity constraint) Cooperativity Tracks Species Movement Allosteric models quantify ligand effects through cooperativity Kenakin highlights a multi-parameter framework in which different cooperativity factors govern interactions implications: Ligand effects are defined by relational parameters, not absolute affinities Multiple cooperativity

and chemistry pulled him into the world of GLP-1R, pancreatic β-cells, and the biological questions David The call from David — the glowing islet — created a pivot the team couldn’t ignore. He learned tissue complexity from David; David picked up the quirks of acetonitrile. David Hodson

David Sykes About Dr. David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD David has over 20+ years of experience working in a drug discovery environment mainly in a specialist In 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology David Sykes on the web Veprintsev Lab ResearchGate LinkedIn Dr. GPCR Unlock the Full Dr.

Davide Calebiro About Dr. Davide Calebiro "Davide Calebiro is Chair of Molecular Endocrinology and Wellcome Trust Senior Research Davide’s work has been published in prestigious scientific journals such as Nature, Cell, New England Davide Calebiro on the web University of Birmingham Twitter Google Scholar LinkedIn Dr.

. << Back to podcast list Strategic Partner(s) David Gloriam: Orphan Receptors, GPCRDB, and the Data intersection of computational biology, cheminformatics, and structural pharmacology through the work of David ABOUT THE GUEST David Gloriam is a professor at the University of Copenhagen's Department of Drug Design Verify against the published audio before use. 00:00 Welcome and introduction of David Gloriam 02:23 Join me a learn more about David’s work, his career trajectory, and GPCRdb. Dr. David E.